CSI Market
Sign In | Register

Shengtai Pharmaceutical (SGTI) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access SGTI quarterly Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Shengtai Pharmaceutical adapts its cash strategy across cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Jun 30 2011)
12 Months 		(Jun 30 2012)
Operating Activities
Income7.65
Depreciation & amortization7.15
Amortization of Other Assets0.06
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.13
Increase (Decrease) in Inventories0.18
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.24
Income (Loss) from Equity Method Investments0.87
Financial Instruments and Foreign Currency Transaction0.00
Increasedecreaseinrelatedpartyaccountspayable-0.56
Reversal Of Officers Compensation-
Income taxes0.27
Losses/ -gains on Investments net0.00
Accounts Receivable8.26
Increase (Decrease) in Due to Related Parties, Total-5.91
Increase (Decrease) in Accrued Liabilities0.00
Increase (Decrease) in Customer Deposits4.48
Increase (Decrease) in Prepaid Expense and Other Assets1.68
Other Working Capital1.10
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities5.07
Investing Activities
Capital Expenditures-2.02
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Proceeds from Advances for Construction-0.94
Payments To Acquire Plant And Equipment-
Construction In Progress Additions-0.13
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Payments to Acquire Equity Method Investments-1.51
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-8.10
Financing Activities
Short-term debt Net6.27
Other borrowing transactions0.00
Long-term debt - borrowings-0.49
Long-term debt - repayments-0.97
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Employee Loans0.03
Repayments Of Employee Loans0.00
Proceeds From Third Party Debt-
Proceeds From Borrowings Unrelated Party-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.18
Effect of exchange rate on cash flow1.13
Discontinued operations0.00
Free Cash Flow3.05
Total Cash Flow-2.09
4 historic quarters locked

Sign in to unlock the full Shengtai Pharmaceutical cash flow history.

Sign In Create Free Account

About SGTI Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License